Barriers to hepatitis C direct-acting antiviral therapy among HIV/hepatitis C virus-coinfected persons.

Lauren P JattMalini M GandhiRong GuoAdam Sukhija-CohenDebika BhattacharyaChi-Hong TsengKara W Chew

Published in: Journal of gastroenterology and hepatology (2020)

In addition to lack of HIV suppression, select antiretroviral regimens, substance use, and kidney disease appeared to limit DAA prescription in the early interferon-free DAA era. Many were not prescribed DAAs despite HIV suppression. Further research is needed to determine if the observed associations persist today.

Keyphrases

hepatitis c virus
human immunodeficiency virus
hiv positive
hiv infected
antiretroviral therapy
hiv aids
hiv testing
men who have sex with men
hiv infected patients
south africa
dendritic cells
stem cells
immune response
mesenchymal stem cells
cell therapy